Trial Profile
A Double Blind, Randomized, Multicentric, Active Controlled, Parallel group, Comparative Phase III study to evaluate the Efficacy and Safety of fixed dose combination of Azilsartan medoxomil and Chlorthalidone versus fixed dose combination of Olmesartan medoxomil and Hydrochlorothiazide in patients with moderate to severe hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Azilsartan medoxomil/chlortalidone (Primary) ; Olmesartan medoxomil/hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Synokem Pharmaceuticals
- 25 Jul 2018 New trial record